Team:Heidelberg

From 2010.igem.org

(Difference between revisions)
Line 138: Line 138:
<img src="https://static.igem.org/mediawiki/2010/e/ed/Slide_CapShuffling.png" alt="" rel="https://static.igem.org/mediawiki/2010/3/30/Slide_CapShuffling_thumb.png"/>
<img src="https://static.igem.org/mediawiki/2010/e/ed/Slide_CapShuffling.png" alt="" rel="https://static.igem.org/mediawiki/2010/3/30/Slide_CapShuffling_thumb.png"/>
<a href="#"><img src="https://static.igem.org/mediawiki/2010/f/fc/Bioinfo.png" alt="" rel="https://static.igem.org/mediawiki/2010/0/0d/Bioinfo_thumb.png"/></a>
<a href="#"><img src="https://static.igem.org/mediawiki/2010/f/fc/Bioinfo.png" alt="" rel="https://static.igem.org/mediawiki/2010/0/0d/Bioinfo_thumb.png"/></a>
-
</div><br><br><br>
+
</div><br><br><br><br>
<div id="pics">
<div id="pics">
Line 175: Line 175:
<html>
<html>
-
<div id="projectabstract"><span class="t3">The key to successful gene therapy</span><br> is integration of tissue specificity and fine-tuned target gene expression. iGEM Team Heidelberg 2010 unlocks the world of synthetic microRNAs. We engineered a toolkit for standardized measurements of interactions between artificial miRNAs and their binding sites. Thus, the expression level of any gene of choice could be arbitrarily adjusted by employing the corresponding binding site design. To produce tissue specific miRNA gene shuttles, we developed an evolution-based method for synthesis of new adeno associated viruses. In the future, miBricks could open the doors to new Synthetic Biology based medical approaches. </div>
+
<div id="projectabstract"><span class="t3">The key to successful gene therapy</span><br>... is integration of tissue specificity and fine-tuned target gene expression. iGEM Team Heidelberg 2010 unlocks the world of synthetic microRNAs. We engineered a toolkit for standardized measurements of interactions between artificial miRNAs and their binding sites. Thus, the expression level of any gene of choice could be arbitrarily adjusted by employing the corresponding binding site design. To produce tissue specific miRNA gene shuttles, we developed an evolution-based method for synthesis of new adeno associated viruses. In the future, miBricks could open the doors to new Synthetic Biology based medical approaches. </div><br><br>
 +
 
<object type="application/x-shockwave-flash" data="http://www.oneplusyou.com/bb/files/countdown/countdown.swf?co=F09600&bgcolor=f2f2f2&date_month=11&date_day=05&date_year=0&un=IGEM JAMBOREE 2010&size=normal&mo=11&da=05&yr=2010" width="250" height="80"><param name="movie" value="http://www.oneplusyou.com/bb/files/countdown/countdown.swf?co=F09600&date_month=11&date_day=05&date_year=0&un=UNTIL IGEM JAMBOREE 2010&size=normal&mo=11&da=05&yr=2010" /><param name="bgcolor" value="#f2f2f2" /></object>
<object type="application/x-shockwave-flash" data="http://www.oneplusyou.com/bb/files/countdown/countdown.swf?co=F09600&bgcolor=f2f2f2&date_month=11&date_day=05&date_year=0&un=IGEM JAMBOREE 2010&size=normal&mo=11&da=05&yr=2010" width="250" height="80"><param name="movie" value="http://www.oneplusyou.com/bb/files/countdown/countdown.swf?co=F09600&date_month=11&date_day=05&date_year=0&un=UNTIL IGEM JAMBOREE 2010&size=normal&mo=11&da=05&yr=2010" /><param name="bgcolor" value="#f2f2f2" /></object>

Revision as of 15:51, 27 October 2010

iGEM Heidelberg Mission 2010: miBricks




Please click a Button to get more information!


The key to successful gene therapy
... is integration of tissue specificity and fine-tuned target gene expression. iGEM Team Heidelberg 2010 unlocks the world of synthetic microRNAs. We engineered a toolkit for standardized measurements of interactions between artificial miRNAs and their binding sites. Thus, the expression level of any gene of choice could be arbitrarily adjusted by employing the corresponding binding site design. To produce tissue specific miRNA gene shuttles, we developed an evolution-based method for synthesis of new adeno associated viruses. In the future, miBricks could open the doors to new Synthetic Biology based medical approaches.


... and way more important: